Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T10:58:22.507Z Has data issue: false hasContentIssue false
  • English
  • Français

A Neuropsychiatrist's Perspective on Selected Dermatoses

Published online by Cambridge University Press:  07 November 2014

Zeina N. Chemali  and
Dany J. Touma
Get access Rights & Permissions [Opens in a new window]

Abstract

Many neuropsychiatric diseases present with concomitant dermatologic manifestations. These manifestations may help the clinician formulate a correct diagnosis when it is otherwise unclear. In this article, we present six cases with clinical photographs of associated skin findings discussed from a neuropsychiatrist's perspective. Each case will be followed by a discussion and a brief review of the associated neuropsychiatric and dermatologic aspects of the disease.

Type
Case Report
Information
CNS Spectrums , Volume 10 , Issue 10 , October 2005 , pp. 784 - 790
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Aboulafia, DM. Kaposi's sarcoma. Clin Dermatol. 2001;19:269–283.CrossRefGoogle ScholarPubMed
2.Heaton, RK, Grant, I, Butters, N, et al.The HNRC 500–neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neurpsychol Soc. 1995;1:231–251.CrossRefGoogle ScholarPubMed
3.Heaton, RK, Marcotte, TD, White, DA, et al.Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clin Neuropsychol. 1996;10:1–14.CrossRefGoogle Scholar
4. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778–785.Google Scholar
5.McArthur, JC, Hoover, Dr, Bacellar, HS, et al.Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. 1993;43:2245–2252.CrossRefGoogle ScholarPubMed
6.Sacktor, N, McDermott, MP, Marder, K, et al.HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8:136–142.CrossRefGoogle ScholarPubMed
7.Nemeroff, CB, Devane, L, Pollock, BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311–320.Google ScholarPubMed
8.Fernandez, F, Levy, JK, Samley, HR, et al.Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiatry Med. 1995;25:53–67.CrossRefGoogle ScholarPubMed
9.Green, J, Kocsis, A. Counseling patients with AIDS-related encephalopathy. J R Coll Physicians Lond. 1988;22:166–168.Google ScholarPubMed
10.Cote, TR, Biggar, RJ, Dannenberg, AL. Risk of suicide among persons with AIDS. A national assessment. JAMA. 1992;268:2066–2068.CrossRefGoogle ScholarPubMed
11.Bessmertny, O, Pham, T. Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Curr Allergy Asthma Rep. 2002;2:34–39.CrossRefGoogle ScholarPubMed
12.Veyrac, G, Marcade, G, Chiffoleau, A, Bourin, M, Jolliet, P. Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes [French]. Therapie. 2002;57:289–296.Google ScholarPubMed
13.Licata, AL, Louis, ED. Anticonvulsant hypersensitivity syndrome. Compr Ther. 1996;22:152–155.Google ScholarPubMed
14.Nigen, S, Knowles, SR, Shear, NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003;2:278–299.Google ScholarPubMed
15.Galindo, PA, Borja, J, Gomez, E, et al.Anticonvulsant drug hypersensitivity. J Investig Allergol Clin Immunol. 2002;12:299–304.Google ScholarPubMed
16.Liu, ZX, Kaplowitz, N. Immune-mediated drug-induced liver disease. Clin Liver Dis. 2002;6:755–774.CrossRefGoogle ScholarPubMed
17.Chopra, S, Levell, NJ, Cowley, G, Gilkes, JJ. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol. 1996;134:1109–1112.CrossRefGoogle ScholarPubMed
18.Berger, BW, Lesser, RL. Lyme disease. Dermatol Clin. 1992;10:763–775.CrossRefGoogle ScholarPubMed
19.Coyle, PK, Schutzer, SE. Neurologic aspects of Lyme disease. Med Clin North Am. 2002;86:261–284.CrossRefGoogle ScholarPubMed
20.Roos, KL. Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases. Semin Neurol. 1998;18:185–196.CrossRefGoogle ScholarPubMed
21.Wang, G, Liveris, D, Brei, B, et al.Real-time PCR for simultaneous detection and quantification of Borrelia burgdorferi in field-collected Ixodes scapularis ticks from the Northeastern United States. Appl Environ Microbiol. 2003;69:4561–4565.CrossRefGoogle ScholarPubMed
22.Nadelman, RB, Nowakowski, J, Fish, D, et al.Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after Ixodes scapularis tick bite. N Engl J Med. 2001;345:79–84.CrossRefGoogle ScholarPubMed
23.Nuss, MA, Carlisle, D, Hall, M, Yemeni, SC, Kovach, R, Trichotillomania: a review and case report. Cutis. 2003;72:191–196.Google ScholarPubMed
24.Bouwer, C, Stein, DJ. Trichobezoars in trichotillomania: case report and literature overview. Psychosom Med. 1998;60:658–660.CrossRefGoogle ScholarPubMed
25.Christenson, GA, Crow, SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry. 1996;57(suppl 8):42–47.Google ScholarPubMed
26.Hautmann, G, Hercogova, J, Lotti, T. Trichotillomania. J Am Acad Dermatol. 2002;46:807–821.CrossRefGoogle ScholarPubMed
27.Khouzam, HR, Battista, MA, Byers, PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry. 2002;65:261–270.CrossRefGoogle ScholarPubMed
28.Koblenzer, CS. Neurotic excoriations and dermatitis artefacta. Dermatol Clin. 1996;14:447–455.CrossRefGoogle ScholarPubMed
29.Gupta, MA, Gupta, AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001;15:512–518.CrossRefGoogle ScholarPubMed
30.Arnold, LM, Auchenbach, MB, McElroy, SL. Psychogenic excoriation, Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2001;15:351–359.CrossRefGoogle ScholarPubMed
31.Metry, DW, Dowd, CF, Barkovich, AJ, Frieden, IJ. The many faces of PHACE syndrome. J Pediatr. 2001;139:117–123.CrossRefGoogle ScholarPubMed
32.Hirsch, JF, Pierre-Kahn, A, Renier, D, Sainte-Rose, C, Hoppe-Hirsch, E. The Dandy-Walker malformation. A review of 40 cases.J Neurosurg. 1984;61:515–522.CrossRefGoogle ScholarPubMed
33.Bruckner, AL, Frieden, IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48:477–493.CrossRefGoogle ScholarPubMed
34.Metry, DW, Hebert, AA. Benign cutaneous vascular tumors in infancy: when to worry, what to do. Arch Dermatol. 2000;136:905–914.CrossRefGoogle ScholarPubMed
35.Al Buainian, H, Verhaeghe, E, Dierckxsens, L, Naeyaert, JM. Early treatment of hemangiomas with lasers. A review. Dermatology. 2003;206:370–373.CrossRefGoogle ScholarPubMed